Acta Scientific Microbiology (ISSN: 2581-3226)

Review Article Volume 5 Issue 7

Monkey Pox: What We Need to Know

Aamir Shafi1*, Ab Ahad Wani2, Jawhar Ul Islam1 and Khibrat Peerzada3

1Registrar, Department of General Medicine, SKIMS Medical College Hospital, Bemina, Srinagar, India

2Assistant Professor, Department of General Medicine, SKIMS Medical College Hospital, Bemina, Srinagar, India

3Junior Resident, Department of General Medicine, SKIMS Medical College Hospital, Bemina, Srinagar, India

*Corresponding Author: Aamir Shafi, Registrar, Department of General Medicine, SKIMS Medical College Hospital, Bemina, Srinagar, India.

Received: June 01, 2022; Published: June 15, 2022


Monkey pox (MP) is a zoonotic orthopox viral infectious disease clinically resembling Small pox but with lesser mortality. First discovered in 1958 in monkeys, the first human infection was documented in 1970. Recently cases have been seen rising in west Europe and North America although in small numbers. India is yet to confirm any case of Monkey pox although many suspects are under surveillance. This review article provides a comprehensive update on how we should be prepared for this emerging viral infection.

Keywords:Monkey Pox; Zoonotic Disease; Ankara Vaccine


  1. Cho CT and Wenner HA. “Monkeypox virus”. Bacteriological Reviews1 (1973): 1-18.
  2. Ladnyj ID., et al. “A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo”. Bulletin of the World Health Organization 5 (1972): 593-597.
  3. Nguyen PY., et al. “Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020”. Emerging Infectious Diseases 4 (2021).
  4. Sklenovská N and Van Ranst M. “Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans”. Frontiers in Public Health 6 (2018): 241.
  5. Alakunle E., et al. “Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution”. Viruses 11 (2020).
  6. Kugelman JR., et al. “Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo”. Emerging Infectious Diseases 2 (2014): 232-239.
  7. Walsh D. “Poxviruses: Slipping and sliding through transcription and translation”. PLoS Pathogen 11 (2017): e1006634.
  8. “Monkeypox”. Weekly Epidemiological Record41 (2007): 448-51.
  9. Centers for Disease Control and Prevention (CDC). “Multistate outbreak of monkeypox--Illinois, Indiana, and Wisconsin, 2003”. Morbidity and Mortality Weekly Report 23 (2003): 537-540.
  10. Erez N., et al. “Diagnosis of Imported Monkeypox, Israel, 2018”. Emerging Infectious Diseases5 (2019): 980-983.
  11. Yong SEF., et al. “Imported Monkeypox, Singapore”. Emerging Infectious Diseases8 (2020): 1826-1830.
  12. Hobson G., et al. “Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021”. Euro Surveillance32 (2021).
  13. Rao AK., et al. “Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021”. Morbidity and Mortality Weekly Report 14 (2022): 509-516.
  14. Costello V., et al. “Imported Monkeypox from International Traveler, Maryland, USA, 2021”. Emerging Infectious Diseases 5 (2022): 1002-1005.
  15. Rimoin AW., et al. “Major increase in human monkeypox incidence 30 years after smallpox vaccination”. (2010).
  16. Kabamba J., et al. “Vaccinating against monkeypox in the Democratic Republic of the Congo”. Antiviral Research 162 (2019): 171-177.
  17. Grant R., et al. “Modelling human-to-human transmission of monkeypox”. Bulletin of the World Health Organization 9 (2020): 638-640.
  18. Hutson CL., et al. “Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study Design”. Biomed Research International 2015 (2015): 965710.
  19. McCollum AM and Damon IK. “Human monkeypox”. Clinical Infectious Diseases 2 (2014): 260-267.
  20. Weaver JR and Isaacs SN. “Monkeypox virus and insights into its immunomodulatory proteins”. Immunology Review 225 (2008): 96-113.
  21. Hussey HS., et al. “Varicella zoster virus-associated morbidity and mortality in Africa: a systematic review protocol”. BMJ Open4 (2016): e010213.


Citation: Aamir Shafi., et al. “Monkey Pox: What We Need to Know". Acta Scientific Microbiology 5.7 (2022): 40-44.


Copyright: © 2022 Aamir Shafi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US